|
TMEM167B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.20080000000223E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.242200E-04 |
| Normal-vs-Stage2 |
4.058500E-03 |
| Normal-vs-Stage3 |
2.209100E-04 |
| Normal-vs-Stage4 |
1.777650E-03 |
| Stage1-vs-Stage2 |
8.250000E-01 |
| Stage1-vs-Stage3 |
1.855450E-01 |
| Stage1-vs-Stage4 |
3.840400E-01 |
| Stage2-vs-Stage3 |
3.794000E-01 |
| Stage2-vs-Stage4 |
4.760200E-01 |
| Stage3-vs-Stage4 |
9.876800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.237300E-04 |
| Normal-vs-AfricanAmerican |
1.395340E-03 |
| Normal-vs-Asian |
1.411620E-01 |
| Caucasian-vs-AfricanAmerican |
6.957600E-01 |
| Caucasian-vs-Asian |
4.697400E-01 |
| AfricanAmerican-vs-Asian |
5.877000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0998999999966E-05 |
| Normal-vs-Female |
3.033500E-02 |
| Male-vs-Female |
7.981800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.083730E-03 |
| Normal-vs-Extreme_Weight |
4.165300E-04 |
| Normal-vs-Obese |
1.499620E-03 |
| Normal-vs-Extreme_Obese |
1.078620E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.358400E-01 |
| Normal_Weight-vs-Obese |
6.548400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.118800E-01 |
| Extreme_Weight-vs-Obese |
8.828600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.406800E-01 |
| Obese-vs-Extreme_Obese |
8.828400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.553000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.041600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.166050E-04 |
| Normal-vs-Age(81-100Yrs) |
2.995800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.060800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.612000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.319600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.340000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.754600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.654200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.824370E-03 |
| Normal-VS-Type2 PRCC |
3.47310000003986E-06 |
| Normal-VS-KIRP CIMP |
7.8324000000074E-05 |
| Normal-VS-Unclassified PRCC |
6.982500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.299770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.272500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.790600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.523800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.254000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.205700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10259999999996E-05 |
| Normal-vs-N1 |
7.62420000000041E-05 |
| Normal-vs-N2 |
9.591800E-01 |
| N0-vs-N1 |
5.503800E-01 |
| N0-vs-N2 |
8.419900E-02 |
| N1-vs-N2 |
7.514000E-02 |
|
|
